Brief synopsis

The concordance between tissue and circulating tumor DNA testing is well-established. However, clinicians may be confronted with discrepant results, especially when performing tissue and liquid testing in parallel, and interpretation may not be so straightforward.

In this Vessel Briefing, we will address some basic concepts and provide case studies to raise awareness about this factor that affects treatment decisions.

Join us on January 12th,  2023. 5PM CET/6PM EET

Please join the conversation and post your comments, thoughts and questions below leading up the the briefing.

This post is for subscribers only

Sign up now to read the post and get access to the full library of posts for subscribers only.

Apply Now Already have an account? Member Login